Published by Abigail Townsend on 10th January 2022
(Sharecast News) - Avacta Group has suspended sales of its antigen lateral flow tests, causing the AIM-listed firm's share price to plummet.
URL: http://www.digitallook.com/dl/news/story/32380592/...